AACR hosts Molecular Diagnostics in Cancer Therapeutic Development Meeting

Premier international meeting highlights breakthroughs in molecular cancer diagnostics research

What:

The AACR Molecular Diagnostics in Cancer Therapeutics Development Meeting features the latest findings in laboratory, translational and clinical cancer research. This year's meeting focuses on new biologic markers and imaging methods.

To help you take advantage of the meeting's scientific abstracts and related activities, the program schedule and related abstracts will be available online at: www.aacr.org on September 22, 2008. The press releases will be available to subscribing reporters on September 15 via Newswise and Eurekalert.

Nearly 100 abstracts will be presented at the meeting, complementing an outstanding program of scientific and educational events. The AACR Molecular Diagnostics in Cancer Therapeutics Meeting attracts world leaders in cancer research, including clinical oncologists, basic scientists and translational researchers.

Highlights:

• Angiogenic factors that increase risk for breast cancer
• Genetic markers for glioblastoma survival
• New data on nanotechnology as a cost effective diagnostic method
• More accurate tools for diagnosing myeloproliferative neoplasia
• Late-breaking data on multispectral imaging and its utility
• How the Epstein Barr virus predicts outcome in nasopharyngeal carcinoma

When:

September 22-25, 2008

Where:

Marriott Philadelphia Downtown
Philadelphia, PA

AACR Press Room:

Location: Room 305, Marriott
Hours: 8:00 a.m. to 6:00 p.m. ET
Phone: (215)-440-9300
Fax: (215)-440-9313
E-mail: emma.obrien@aacr.org

Hotel Accommodations:

Register for housing online at:
http://www.aacr.org/page14413.aspx
(Deadline for AACR housing block at the Marriott Hotel is Aug.29, 2008, contact hotel directly for post-deadline accommodations)

Contact/Press Registration:

AACR
(267) 646-0613
Emma O'Brien (emma.obrien@aacr.org)